New program aims to keep young diabetics on track with glucose monitoring
NCT ID NCT05854069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called FAMS that helps young adults aged 18-24 with type 1 diabetes use their continuous glucose monitor (CGM) more often. Participants include 140 CGM users who also have high blood sugar or diabetes distress. The goal is to see if the program reduces gaps in CGM use and improves how they respond to glucose data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Smart insulin pump aims to end dangerous nighttime blood sugar swings
- Could diabetes be silently damaging your hearing?
- Hidden liver risk in type 1 diabetes: a new study investigates
- Can a wearable sensor outsmart diabetic ketoacidosis?
- Art as medicine: can drawing and painting help sick kids feel better about themselves?